Control da Regulación Xénica en Enfermidades
Regulación Xénica
![Foto de Control da Regulación Xénica en Enfermidades](/img/grupo.png)
![Foto de Hospital Universitario de Donostia](/img/noimage_org.png)
Hospital Universitario de Donostia
San Sebastián, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de Donostia (6)
2022
-
Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs
Cancers, Vol. 14, Núm. 19
2021
-
E2F1 and E2F2-mediated repression of CPT2 establishes a lipid-rich tumor-promoting environment
Cancer Research, Vol. 81, Núm. 11, pp. 2874-2887
2019
-
Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease
Hepatology, Vol. 69, Núm. 2, pp. 699-716
-
SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer
EBioMedicine, Vol. 40, pp. 406-421
2018
-
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
Cell Death and Disease, Vol. 9, Núm. 10
2015
-
Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1
Hepatology, Vol. 62, Núm. 4, pp. 1237-1248